LawLoveLegal

Health Ministry Introduces New Shorter and More Effective Treatment Regimen for Drug-Resistant TB in India Under the leadership of Prime Minister Narendra Modi and in line with India's goal to eliminate tuberculosis (TB) by 2025, the Union Ministry of Health and Family Welfare has approved the introduction of the BPaLM regimen for treating multi-drug-resistant tuberculosis (MDR-TB). This new regimen promises a more efficacious and shorter treatment duration, making it a breakthrough for the country’s National TB Elimination Programme (NTEP). Introduction of the BPaLM Regimen The BPaLM regimen includes a combination of four drugs: Bedaquiline, Pretomanid, Linezolid, and Moxifloxacin. Among these, Pretomanid, a new anti-TB drug, was previously approved and licensed for use in India by the Central Drugs Standard Control Organisation (CDSCO). The combination of these drugs provides a highly effective, shorter, and safer treatment alternative for MDR-TB patients. This new regimen is a s...